View in EDS

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.

Saved in:
Bibliographic Details
Title: Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.
Authors: Rothenberg ML; The University of Texas Health Science Center San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu, Kuhn JG, Schaaf LJ, Rodriguez GI, Eckhardt SG, Villalona-Calero MA, Rinaldi DA, Hammond LA, Hodges S, Sharma A, Elfring GL, Petit RG, Locker PK, Miller LL, von Hoff DD
Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2001 Nov; Vol. 12 (11), pp. 1631-41.
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Print ISSN: 0923-7534 (Print) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 11822765
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rothenberg+ML%22">Rothenberg ML</searchLink>; The University of Texas Health Science Center San Antonio, USA. mace.rothenberg@mcmail.vanderbilt.edu<br /><searchLink fieldCode="AU" term="%22Kuhn+JG%22">Kuhn JG</searchLink><br /><searchLink fieldCode="AU" term="%22Schaaf+LJ%22">Schaaf LJ</searchLink><br /><searchLink fieldCode="AU" term="%22Rodriguez+GI%22">Rodriguez GI</searchLink><br /><searchLink fieldCode="AU" term="%22Eckhardt+SG%22">Eckhardt SG</searchLink><br /><searchLink fieldCode="AU" term="%22Villalona-Calero+MA%22">Villalona-Calero MA</searchLink><br /><searchLink fieldCode="AU" term="%22Rinaldi+DA%22">Rinaldi DA</searchLink><br /><searchLink fieldCode="AU" term="%22Hammond+LA%22">Hammond LA</searchLink><br /><searchLink fieldCode="AU" term="%22Hodges+S%22">Hodges S</searchLink><br /><searchLink fieldCode="AU" term="%22Sharma+A%22">Sharma A</searchLink><br /><searchLink fieldCode="AU" term="%22Elfring+GL%22">Elfring GL</searchLink><br /><searchLink fieldCode="AU" term="%22Petit+RG%22">Petit RG</searchLink><br /><searchLink fieldCode="AU" term="%22Locker+PK%22">Locker PK</searchLink><br /><searchLink fieldCode="AU" term="%22Miller+LL%22">Miller LL</searchLink><br /><searchLink fieldCode="AU" term="%22von+Hoff+DD%22">von Hoff DD</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229007735%22">Annals of oncology : official journal of the European Society for Medical Oncology</searchLink> [Ann Oncol] 2001 Nov; Vol. 12 (11), pp. 1631-41.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9007735 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0923-7534 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209237534%22">09237534 </searchLink><i>NLM ISO Abbreviation: </i>Ann Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11822765
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1023/a:1013157727506
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1631
    Titles:
      – TitleFull: Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rothenberg ML
      – PersonEntity:
          Name:
            NameFull: Kuhn JG
      – PersonEntity:
          Name:
            NameFull: Schaaf LJ
      – PersonEntity:
          Name:
            NameFull: Rodriguez GI
      – PersonEntity:
          Name:
            NameFull: Eckhardt SG
      – PersonEntity:
          Name:
            NameFull: Villalona-Calero MA
      – PersonEntity:
          Name:
            NameFull: Rinaldi DA
      – PersonEntity:
          Name:
            NameFull: Hammond LA
      – PersonEntity:
          Name:
            NameFull: Hodges S
      – PersonEntity:
          Name:
            NameFull: Sharma A
      – PersonEntity:
          Name:
            NameFull: Elfring GL
      – PersonEntity:
          Name:
            NameFull: Petit RG
      – PersonEntity:
          Name:
            NameFull: Locker PK
      – PersonEntity:
          Name:
            NameFull: Miller LL
      – PersonEntity:
          Name:
            NameFull: von Hoff DD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2001 Nov
              Type: published
              Y: 2001
          Identifiers:
            – Type: issn-print
              Value: 0923-7534
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Annals of oncology : official journal of the European Society for Medical Oncology
              Type: main
ResultId 1